Pharmena S.A.
PHR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 42,658 | PLN 79,078 | PLN 62,371 | PLN 87,881 |
| - Cash | PLN 1,745 | PLN 22,237 | PLN 1,592 | PLN 1,460 |
| + Debt | PLN 244 | PLN 183 | PLN 10,143 | PLN 9,709 |
| Enterprise Value | PLN 41,157 | PLN 57,024 | PLN 70,922 | PLN 96,130 |
| Revenue | PLN 268 | PLN 9,837 | PLN 299 | PLN 15,213 |
| % Growth | -97.3% | 3,190% | -98% | – |
| Gross Profit | PLN 198 | PLN 5,843 | PLN 10,335 | PLN 7,832 |
| % Margin | 73.9% | 59.4% | 3,456.5% | 51.5% |
| EBITDA | -PLN 3,382 | PLN 35,552 | -PLN 129 | -PLN 3,515 |
| % Margin | -1,261.9% | 361.4% | -43.1% | -23.1% |
| Net Income | -PLN 1,262 | PLN 28,941 | -PLN 1,570 | -PLN 4,592 |
| % Margin | -470.9% | 294.2% | -525.1% | -30.2% |
| EPS Diluted | -0.11 | 2.6 | -0.14 | -0.41 |
| % Growth | -104.2% | 1,957.1% | 65.9% | – |
| Operating Cash Flow | -PLN 2,531 | PLN 33,032 | PLN 1,819 | -PLN 3,225 |
| Capital Expenditures | -PLN 180 | -PLN 314 | -PLN 226 | -PLN 319 |
| Free Cash Flow | -PLN 2,711 | PLN 32,718 | PLN 1,593 | -PLN 3,544 |